Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

People with lichen planus have higher bad cholesterol and lower good cholesterol, increasing their risk for heart disease.

Genetic variations affecting skin structure play a key role in severe acne.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.